medline.ch Onkologie Respirationstrakt

	LEPR Contributes to Lung Squamous Cell Carcinoma: Insights From Mendelian Randomization and Experimental Studies. Cancer Inform Hu W, Wu G, Lin Y, Li S, Lin Z, Chen Y, Cheng Z, Zeng J, Yang Z, Wang Y. PMID: 42261303 [PubMed]
	Prognostic role of the systemic immune-inflammation in patients with non-small cell lung cancer: A meta-analysis. J Pak Med Assoc Zhao G, Zhang H, Ye P, Chen W. PMID: 42261026 [PubMed - in process]
	miR-130a-3p regulates the occurrence and progression of lung squamous cell carcinoma by activating ZDHHC5 and immune cell-related pathways. Medicine (Baltimore) Li W, Xia B, Deng S. PMID: 42260863 [PubMed - in process]
	Addressing Data Quality Challenges in Lung Cancer Data Within the Observational Medical Outcomes Partnership Common Data Model: Observational Study. J Med Internet Res Declerck J, Deschepper M, Colpaert K, Kalra D, Coorevits P. PMID: 42258805 [PubMed - in process]
	Predicting 5-Year Mortality in Non-Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study. JMIR Med Inform Lee JH, Kim HC, Jung KW, Choi CM. PMID: 42258797 [PubMed - in process]
	Diagnostic Performance of the Cancer Ratio in Malignant Pleural Effusion in Combination with the Light's Criteria. Acta Med Port Cavaco MJ, Fontão Alves S, Silva C, Pimentel S, Mateus L, Rôlo Silvestre C, Ferra J, Duarte D, Cardoso C, Raimundo P, Falcão T. PMID: 42258379 [PubMed - as supplied by publisher]
	Fascin-1 expression in non-small cell lung cancer and its diagnostic implications. Discov Oncol Wang Y, Lu SP, Jiang LJ, Shao JK, Du ZQ, Lu HJ, Huang BF, Wang CQ. PMID: 42258099 [PubMed - as supplied by publisher]
	Decoding Molecular Signatures for miRNA-Based Biosensor Platforms from Nanoscale Engineering to Lung Cancer Diagnostics. Anal Chem Kohli A, Dhigan R, Yadav S, Rani V. PMID: 42257283 [PubMed - as supplied by publisher]
	Clinical effects of the Collaborative Care Model on pulmonary function and quality of life in postoperative patients with lung cancer. Pak J Med Sci Liu P, Liu C, Liu W, Qi X, Shi C, Cao H. PMID: 42257069 [PubMed]
	Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant non-small cell lung cancer (NEOTIDE/CTONG2104): phase II trial and correlative genomic analysis in China. EClinicalMedicine Zhang C, Jiang BY, Yan LX, Peng LS, Li JH, Chen ZY, Sun YX, Su J, Liao RQ, Dong S, Yan HH, Xu CR, Zhou Q, Yang XN, Hu Z, Wu YL, Zhong WZ. PMID: 42256683 [PubMed]
	Treatment decision-making for leptomeningeal metastasis after TKI resistance in EGFR-mutant lung cancer: a comprehensive review on staging, resistance patterns, and multimodal interventions. Front Neurol Song GQ, He TL, Ji KJ, Duan YM, Hu GQ. PMID: 42256578 [PubMed]
	Precision Medicine in Treating Lung Cancer: A Narrative Review on Treatments Targeting Oncogenic Genetic Mutations. Cureus Chitneni E, Venugopal A, Okorie CO, George AT, Arya A, Arias D, Yasin O, Cereser Prado de Souza L, Afshan R, Dave VA. PMID: 42255853 [PubMed]
	Association between the prognostic nutritional index and prognosis in patients with non-small cell lung cancer undergoing curative lung resection: a systematic review and meta-analysis. Front Oncol Wu S, Jiang X, Han G. PMID: 42255221 [PubMed]
	Multidisciplinary Approach to Sexual Dysfunction in Persons With Lung Cancer-Spanish Lung Cancer Group Expert Consensus Statement. JTO Clin Res Rep Ospina-Serrano AV, Maximiano-Alonso C, Guillén-Sentís P, Losada B, Cruz-Castellanos P, López-Castro R, Campos-Balea B, Azkona-Uribelarrea E, Cardeña A, Valdivia A, Olivares-Hernández A, Blasco-Cordellat A, Sereno-Moyano M, Peralta-Tanco D, Dómine M, Romão R, Muñoz-Borrajo S, Garcia-Espantaleon M, Pereira-Sánchez A, Fernández-Pascual E, Torremadé-Barreda J, Montejo AL, Larrazabal M, Martin-Romo CC, Alvarez-Garcia R, Sánchez F, Calvo V, Provencio-Pulla M. PMID: 42254938 [PubMed]
	Hypothesis Generation via Interpretable Machine Learning: A Case Study on Risk Factors for Postradiation Therapy Lung Cancer Recurrence. Adv Radiat Oncol Zhang Z, Lee SH, Caruana R, Nori H, Fan Y, Wang X, Yegya-Raman N, Simone CB 2nd, Kao GD, Feigenberg SJ, Xiao Y. PMID: 42254819 [PubMed]
	Organ-specific pre-metastatic and metastatic niches in colorectal cancer: "discrepancy in response to immune checkpoint inhibitors in liver and lung metastasis". Front Immunol Mourad M, Al Mahmasani L, Abbas N, Shamseddine A. PMID: 42253947 [PubMed - in process]
	Gas Biopsy of Pleural Effusion to Diagnose Lung Cancer by Mass Spectrometry. MedComm (2020) Liu W, Qi J, Chu Y, Zhou J, Liu Y, Ke L, Zheng X, Lu Y, Ge D, Chu Y, Wang H. PMID: 42253921 [PubMed]
	Practice-Changing Advances in Systemic Therapies Shaping the Landscape of Lung Cancer in 2025. Cancer Innov Zhou Z, Gao W, Li MSC, Zhou Q. PMID: 42253855 [PubMed]
	Final Analysis of Neoadjuvant Sintilimab Plus Chemotherapy in IB-IIIA Non-Small-Cell Lung Cancer: Phase 2 neoSCORE Trial. Cancer Sci Shao M, Yao J, Zhao L, Zhu L, Li B, Li L, Zhou B, Zhang Y, Liu H, Chen X, Wu Z, Chen Z, Fan J, Qiu F. PMID: 42252705 [PubMed - as supplied by publisher]
	Retrospective Analysis of HER2 Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC With HER2 Mutations in France. Cancer Med Debieuvre D, Macouillard P, Quantin X, Berktas M, Girard N, Audigier-Valette C, Filleron T, Musilli S, Bosquet L, Pérol M. PMID: 42252502 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 159281

Seite 1 von 7965

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung